a new oral bisphosphonate for osteoporosis called Boniva (ibandronate)

December 2004

In 2005 you'll see a new oral bisphosphonate for osteoporosis called Boniva (ibandronate).

It'll be the first one approved for dosing once a MONTH.

Bisphosphonates are good candidates for intermittent dosing. They can remain active in the bone for several weeks or longer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote